Canada Research Roundup: Alithya Group, Gen Iii Oil, Khiron Life Sciences

Alithya

12/06/2019 12:50

June 12 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Alithya Group, Gen Iii Oil and Khiron Life Sciences on Wednesday. 
    
  HIGHLIGHTS    
     * Alithya Group Inc  ALYA.TO : Desjardins cuts target price to C$5.75 from C$6.75
     * Gen Iii Oil Corp  GIII.V : Canaccord Genuity cuts target price to C$1 from C$1.20
     * Khiron Life Sciences  KHRN.V : Canaccord Genuity raises price target to C$6.75 from C$6
        
Following is a summary of research actions on Canadian companies reported by Reuters on
Wednesday. Stock entries are in alphabetical order.             
     * AGF Management Ltd  AGFb.TO : RBC cuts target price to C$6 from C$6.50
     * Alithya Group Inc  ALYA.TO : Desjardins cuts target price to C$5.75 from C$6.75
     * Cascades Inc  CAS.TO : TD Securities raises to buy from hold 
     * Cascades Inc  CAS.TO : TD Securities raises target price to C$11.50 from C$11
     * Gen Iii Oil Corp  GIII.V : Canaccord Genuity cuts target price to C$1 from C$1.20
     * Keyera Corp  KEY.TO : GMP cuts target price to C$33.50 from C$34.50
     * Khiron Life Sciences  KHRN.V : Canaccord Genuity raises price target to C$6.75 from C$6
 
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))